Annual ROE
-2.97%
-3.59%-579.03%
December 31, 2023
Summary
- As of February 25, 2025, CTKB annual return on equity is -2.97%, with the most recent change of -3.59% (-579.03%) on December 31, 2023.
- During the last 3 years, CTKB annual ROE has risen by +118.14% (+97.55%).
- CTKB annual ROE is now -107.36% below its all-time high of 40.35%, reached on December 31, 2019.
Performance
CTKB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-2.57%
+1.79%+41.06%
September 30, 2024
Summary
- As of February 25, 2025, CTKB quarterly return on equity is -2.57%, with the most recent change of +1.79% (+41.06%) on September 30, 2024.
- Over the past year, CTKB quarterly ROE has increased by +0.78% (+23.28%).
- CTKB quarterly ROE is now -123.71% below its all-time high of 10.84%, reached on September 30, 2021.
Performance
CTKB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CTKB ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -579.0% | +23.3% |
| 3 y3 years | +97.5% | -79.7% |
| 5 y5 years | -107.4% | -79.7% |
CTKB ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -292.9% | at low | -231.1% | +41.1% |
| 5 y | 5-year | -107.4% | +97.5% | -123.7% | +98.0% |
| alltime | all time | -107.4% | +97.5% | -123.7% | +98.0% |
Cytek Biosciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -2.57%(-41.1%) |
| Jun 2024 | - | -4.36%(+55.2%) |
| Mar 2024 | - | -2.81%(-3.8%) |
| Dec 2023 | -2.97%(-579.0%) | -2.92%(-12.8%) |
| Sep 2023 | - | -3.35%(+134.3%) |
| Jun 2023 | - | -1.43%(+169.8%) |
| Mar 2023 | - | -0.53%(-185.5%) |
| Dec 2022 | 0.62% | 0.62%(-219.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -0.52%(-29.7%) |
| Jun 2022 | - | -0.74%(-300.0%) |
| Mar 2022 | - | 0.37%(-81.1%) |
| Dec 2021 | 1.54%(-101.3%) | 1.96%(-81.9%) |
| Sep 2021 | - | 10.84%(-110.3%) |
| Jun 2021 | - | -105.50%(-19.4%) |
| Mar 2021 | - | -130.88%(+8.1%) |
| Dec 2020 | -121.11%(-400.1%) | -121.11% |
| Dec 2019 | 40.35% | - |
FAQ
- What is Cytek Biosciences annual return on equity?
- What is the all time high annual ROE for Cytek Biosciences?
- What is Cytek Biosciences annual ROE year-on-year change?
- What is Cytek Biosciences quarterly return on equity?
- What is the all time high quarterly ROE for Cytek Biosciences?
- What is Cytek Biosciences quarterly ROE year-on-year change?
What is Cytek Biosciences annual return on equity?
The current annual ROE of CTKB is -2.97%
What is the all time high annual ROE for Cytek Biosciences?
Cytek Biosciences all-time high annual return on equity is 40.35%
What is Cytek Biosciences annual ROE year-on-year change?
Over the past year, CTKB annual return on equity has changed by -3.59% (-579.03%)
What is Cytek Biosciences quarterly return on equity?
The current quarterly ROE of CTKB is -2.57%
What is the all time high quarterly ROE for Cytek Biosciences?
Cytek Biosciences all-time high quarterly return on equity is 10.84%
What is Cytek Biosciences quarterly ROE year-on-year change?
Over the past year, CTKB quarterly return on equity has changed by +0.78% (+23.28%)